HUN KIM: Open Payments
NPI 1265164024 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,373 in 102 payments from 17 companies in 2025. Trend: 2023 $157 · 2024 $1,578 · 2025 $2,373
Food & beverage: $2,307Education: $66
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 22 | $448 |
| Regeneron Healthcare Solutions, Inc. | 13 | $354 |
| ABBVIE INC. | 13 | $289 |
| Novartis Pharmaceuticals Corporation | 7 | $202 |
| GENZYME CORPORATION | 5 | $160 |
| Lilly USA, LLC | 7 | $156 |
| Arcutis Biotherapeutics, Inc. | 5 | $121 |
| Incyte Corporation | 5 | $113 |
| UCB, Inc. | 5 | $109 |
| PFIZER INC. | 4 | $82 |
Products named: DUPIXENT, TREMFYA, RINVOQ, COSENTYX, TALTZ, Zoryve, OPZELURA, Bimzelx.
Industry payments across NY — which companies pay providers there.
